Skip to content

Clinical trials

Phase 3 Cerebrovascular Disorders trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cerebrovascular Disorders Phase: Phase 3 Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20141
20182
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Beijing Tiantan Hospital1
Chinese University of Hong Kong1
Guangdong Provincial Hospital of Traditional Chinese Medicine1
Neuroscience Trials Australia1
Remedy Pharmaceuticals, Inc.1
The George Institute for Global Health, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cerebrovascular Disorders7
Cardiovascular Diseases4
Stroke4
Brain Diseases2
Central Nervous System Diseases2
Ischemic Stroke2
Vascular Diseases2
Arthritis1
Brain Edema1
Brain Infarction1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.